The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic mechanisms of resistance to neoadjuvant leuprolide plus abiraterone in locally advanced prostate cancer.
 
Adam G. Sowalsky
No Relationships to Disclose
 
Huihui Ye
No Relationships to Disclose
 
Rachel J. Schaefer
No Relationships to Disclose
 
Olga S. Voznesensky
No Relationships to Disclose
 
Zhenwei Zhang
No Relationships to Disclose
 
Rosina Lis
No Relationships to Disclose
 
Glenn J. Bubley
No Relationships to Disclose
 
Mary-Ellen Taplin
Honoraria - Bayer; Dendreon; Janssen-Ortho; Medivation; Tokai Pharmaceuticals
Consulting or Advisory Role - Bayer; Best Doctors, Inc; Clovis Oncology; Dava Oncology; Dendreon; Gerson Lehrman Group; Guidepoint Global; Janssen-Ortho; Medivation; Parexel; Research to Practice; Sanofi; Tokai Pharmaceuticals; UpToDate
Research Funding - Bayer; Genentech; Janssen-Ortho; Medivation; Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Oncology; Medivation; Tokai Pharmaceuticals
 
Steven P. Balk
Research Funding - Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - NKT Therapeutics
Expert Testimony - Astellas Oncology